Table 5.
Protective role of Mox against MnCl2-induced meristematic cell damage.
| Groups | ECD | FCD | CCD | TCCD |
|---|---|---|---|---|
| C | − | − | − | − |
| Mox 1 | − | − | − | − |
| Mox 2 | − | − | − | − |
| MnCl2 | +++ | +++ | +++ | ++ |
| MnCl2 + Mox 1 | ++ | ++ | ++ | + |
| MnCl2 + Mox 2 | + | + | + | − |
C: Control, Mox 1: 250 mg/L M. officinalis leaf extract, Mox 2: 500 mg/L M. officinalis leaf extract, MnCl2: 1000 µM MnCl2, MnCl2 + Mox 1: 1000 µM MnCl2 + 250 mg/L M. officinalis leaf extract, MnCl2 + Mox 2: 1000 µM MnCl2 + 500 mg/L M. officinalis leaf extract. ECD: epidermis cell damage, FCN: flattened cell nucleus, CCD: cortex cell damage, TCCD: thickening of the cortex cell wall (−): no damage, ( +): slight damage, (++): moderate damage, (+++): substantial damage.